ClinicalTrials.gg
RecruitingNCT07340242Updated Jan 14, 2026

Dentoskeletal Effects of 3D-Printed Fixed Twin Block Versus MARA Appliances in Management of Skeletal Class II

An interventional study of MARA appliance and fixed twin block in Class II Malocclusion and Mandibular Deficiency, sponsored by Mansoura University. Recruiting at 1 site in Egypt. Open to participants aged 9 Years to 14 Years. Per ClinicalTrials.gov, last updated 2026-01-14.

Sponsored by Mansoura University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Apr 2025, registered Nov 2025).
  • Started Apr 2025; still recruiting 1 year 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
9 Years to 14 Years
Sex
All
01

Study summary

Objective: to evaluate the dentoskeletal effects of CAD/CAM 3D-Printed fixed twin block versus MARA appliances in the management of skeletal class II due to Mandibular Deficiency in Preadolescence Class II malocclusion is considered one of the most commonly observed problems among orthodontic patients, representing around one-third of the patients seeking orthodontic treatment reflecting a significant economic impact. Various removable and fixed functional appliances are commonly used to stimulate mandibular growth. Fixed Twin-block appliance has advantages compared with removable Twin-block and Herbst appliances. The mandibular anterior repositioning appliance is referred to as M.A.R.A. appliance.

Materials and method: The study design is a randomized controlled trial in which the control group and intervention groups will be assessed as parallel groups with a 1:1:1 allocation ratio. Sixty subjects will be enrolled in this research. They will be divided equally into three groups: untreated control, MARA group and Twin block group

02

Conditions studied

  • Class II Malocclusion
  • Mandibular Deficiency

Browse trials for

03

In context

Micrognathism

26 studies on the registry are indexed under Micrognathism; 7 are open to participants now.

This study's planned enrollment of 60 is above the median of 24 across 22 interventional studies indexed under Micrognathism.

Browse Micrognathism studies →

Lead sponsor

Mansoura University is the lead sponsor of 1,119 studies on the registry; 183 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Skeletal Class II malocclusion due to mandibular retrusion.
  2. Overjet ≥ 6.0 mm.
  3. Normal or low-angle growth pattern.
  4. Minimum crowding in the mandibular arch.
  5. Undergoing circumpubertal phase of skeletal development (CVMI 2, 3, and 4)

Exclusion criteria

Exclusion Criteria:

  1. Clinical signs and symptoms of temporomandibular disorder.
  2. Systemic disease affecting bone and general growth.
  3. Previous orthodontic treatment
  4. Cleft lip or palate.
  5. Congenital craniofacial deformity.
  6. Abnormal oral habits.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • No intervention
    Control group, who will be the untreated group.
  • Active comparator
    . MARA group, who will undergo MARA appliance

    Device: MARA appliance

  • Active comparator
    Fixed twin block group, who will undergo fixed twin block appliance

    Device: fixed twin block

Interventions

  • DeviceMARA appliance

    CAD/CAM 3D printed mandibular anterior repositioning appliance

  • Devicefixed twin block

    CAD/CAM 3D printed fixed twin block

06

What researchers measure

Primary outcomes

  1. Linear Skeletal changes of the maxilla and mandible using cephalometric measurements

    linear (mm) measurement

    Time frame: From date of randomization until the date of first documented acceptable correction assessed up to 6 months

  2. Angular skeletal changes of the maxilla and mandible using cephalometric measurements

    angular (°) measurement

    Time frame: From date of randomization until the date of first documented acceptable correction assessed up to 6 months

  3. Linear dental changes of the maxilla and mandible using cephalometric measurements

    linear (mm) measurement

    Time frame: From date of randomization until the date of first documented acceptable correction assessed up to 6 months

  4. Angular dental changes of the maxilla and mandible using cephalometric measurements

    angular (°) measurement

    Time frame: From date of randomization until the date of first documented acceptable correction assessed up to 6 months

  5. Linear soft tissue changes of the maxilla and mandible using cephalometric measurements

    linear (mm) measurement

    Time frame: From date of randomization until the date of first documented acceptable correction assessed up to 6 months

  6. Angular soft tissue changes of the maxilla and mandible using cephalometric measurements

    angular (°) measurement

    Time frame: From date of randomization until the date of first documented acceptable correction assessed up to 6 months

Secondary outcomes

  1. Oral health quality of life questionnaire

    The questionnaire (COHIP-SF-AR) will be given to the participants once informed consent is obtained at 5-time points: before treatment, 1 week, 1 month, 3 months, and 6 months after wearing functional appliances.

    Time frame: From date of randomization until the date of first documented acceptable correction assessed up to 6 months

  2. Incidence of breakages and harms reported during routine or emergency visits in both groups

    Details of complications in both groups, including breakages and harms reported during routine or emergency visits, will be registered and categorized according to their nature and severity using a previously published classification system

    Time frame: From date of randomization until the date of first documented acceptable correction assessed up to 6 months

  3. Arch perimeter and depth measurement from digital model analysis

    linear (mm) measurement

    Time frame: From date of randomization until the date of first documented acceptable correction assessed up to 6 months

  4. Maxillary inter-canine width from digital model analysis

    linear (mm) measurement

    Time frame: From date of randomization until the date of first documented acceptable correction assessed up to 6 months

  5. Maxillary inter-first molar width from digital model analysis

    linear (mm)measurement

    Time frame: From date of randomization until the date of first documented acceptable correction assessed up to 6 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2025 (actual). Primary completion is estimated for Oct 2026, 17 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 21, 2025
First posted
Jan 14, 2026
StartActual
Apr 27, 2025
Primary completionEst.
Oct 15, 2026
CompletionEst.
Apr 27, 2027
Last update
Jan 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07340242
Responsible party
Yasmin Ghaly (Assistant Lecturer, Mansoura University) — Principal investigator
First posted
Jan 14, 2026
Start date
Apr 27, 2025
Primary completion
Oct 15, 2026 (estimated)
Completion
Apr 27, 2027 (estimated)
Last update
Jan 14, 2026

Study contacts

Yasmin s Ghaly, phd
Contact
yasminghaly@mans.edu.eg
+201065152020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion